Database Proof Substratum: Substratum of Proof LGBTQs Are Mentally Ill: Clinical Trial Does Not Support the Use of Bortezomib for Kidney Transplant Recipients

Gendrome Editors' Note: The article below provides the raw material for a proof and is not the proof itself. In addition, the raw material may contain one or more false statements and/or some offensive, outside content.

* In a trial of kidney transplant recipients with late antibody-mediated rejection, treatment with bortezomib, a type of proteasome inhibitor, failed to improve the function of transplanted kidneys and prevent immunologic tissue injury. * Bortezomib treatment was also linked with gastrointestinal and hematologic toxicity.